Nvidia.
AFP (via Getty Images)
NVIDIA has always strived to invest in valuable innovation. The company’s decades-long commitment to developing meaningful products and revolutionizing the hardware industry has almost paid off. From its inventive efforts in the gaming space to its latest advances in chips essential to the development of generative AI, the company has undoubtedly been successful.
But while most people think of NVIDIA as a pure hardware organization, the company is rapidly investing resources in other areas, and its venture capital arm, NVentures, has a large number of investments into healthcare. is leading the way in investment.
The VC arm’s latest investment was announced earlier this month and involves a significant contribution to Hippocratic AI, a company seeking to build large-scale, safety-focused language models for healthcare, along with other investment partners. It was something. Specifically, Hippocrates AI is designed to use secure and We aim to realize artificial health general intelligence (HGI). The collaboration with NVIDIA will enable the startup to “extend its production platform to provide low-latency, long-context conversation capabilities” (including) prefix caching, speculative decoding, prefill/decode decomposition, and more. , several techniques tailored for real-time long-context conversational AI. ”
Kimberly Powell, Vice President of Healthcare at NVIDIA, explains: “Generative AI is expanding the healthcare industry and its ability to meet the growing demands of patient care, and Hippocratic AI is leveraging technology to increase access to healthcare. ..Corporate Safety – A focused approach uses advanced Nvidia technology to make personalized, real-time patient interactions more natural and competent, building trust among patients and clinicians alike. It will help you build.”
NVentures has invested in many more potentially innovative companies. Another investment is Moon Surgical, a French company working to develop advanced and state-of-the-art robotic surgical systems. Robotic surgical systems themselves are not new. In fact, Intuitive Surgical’s da Vinci robotic system is one of the most widely used platforms in the world and has revolutionized the field of minimally invasive surgery. In fact, Moon Surgical, whose board of directors includes the founders of Intuitive Surgical, wants to redefine the future of the operating room by enabling efficient and adaptable technology. Partnering with NVIDIA could unlock a lot of functionality, as NVIDIA is already working with them leveraging the Clara Holoscan platform. Anne Osdoit, CEO of Moon Surgical, said: “NVIDIA knows all the hardware and software with optimized architectures and libraries. With Clara Holoscan, we don’t have to worry about things that typically take up a lot of time in medical device development. ” cycle. “
Another investment example is CHARM Therapeutics, which focuses on leveraging deep learning capabilities to accelerate drug discovery. Through this partnership, CHARM will leverage NVIDIA’s capabilities to use advanced machine learning to identify new ways proteins fold, thereby enabling the development of new therapeutics. Indeed, if this is successful, NVIDIA and CHARM will join other tech giants similarly interested in the intersection of computational science and biology, such as Alphabet and Google DeepMind’s work on AlphaFold 3 and Meta’s work with ESM. You will be competing with Atlas.
NVentures is also involved in the field of medical imaging, recognizing that it is one of the most data-rich aspects of the healthcare industry. The company has invested in Flywheel, which leverages AI to “transform complex image data into analyzable datasets to accelerate research and AI development.” said Mohamed “Sid” Siddeek, Corporate Vice President and Head of NVentures. “Applications of AI are enabling the discovery of new drugs, identifying disease patterns, and improving patient care…Flywheel uses AI to unlock value in healthcare Imaging data is applying AI across the healthcare industry It shows that there are lasting benefits to doing so.”
Most of the companies in which NVentures has invested, including these startups, offer promising prospects for their potentially expanding impact in technology and healthcare. Additionally, with NVIDIA on board as a collaborative partner, these companies will greatly benefit from the technology and hardware giant’s decades of experience in advanced computing. Similarly, for NVIDIA, these investments represent an opportunity to truly expand the company’s already significant influence in the field of artificial intelligence and technology in general.
